Moreover, the lower number of hypoglycemic episodes associated with reduced insulin therapy (both subcutaneous and intravenous) resulting from minor stress admission hyperglycemia further corroborated the reduced in-hospital occurrence of arrhythmias in SGLT2-i users. Here, INS is linked to cardiac arrhythmia.